Identification and characteristics of time-related shifts in suicide-related event frequency during smoking cessation treatment with varenicline - Akimoto H, Wakiyama H, Oshima S, Negishi A, Ohara K, Numajiri S, Okita M, Ohshima S, Inoue N, Kobayashi D.
OBJECTIVES: To survey time-related shifts in number of suicide-related events (SRE) during smoking cessation treatment with varenicline (VAR) in cases from the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), as well as the c... (Source: SafetyLit)
Source: SafetyLit - September 22, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
A Single Drug Could One Day Treat Pain, Memory Loss And Nicotine Addiction
Pain, memory problems and nicotine addiction are formidable problems that have quite different consequences. But in terms of what’s happening in the brain that causes people to suffer from each, they share a close connection. And now scientists say one drug might be able to help people with all three of these problems.
Estimates suggest 2 million people in the U.S. suffered from an opioid abuse disorder in 2015 (the most recent year with data available), about 5 million Americans are currently living with Alzheimer’s disease and more than 36 million Americans are currently cigarette smokers (more than half of w...
Source: Healthy Living - The Huffington Post - May 31, 2017 Category: Consumer Health News Source Type: news
A Single Drug Could One Day Treat Pain, Memory Loss And Nicotine Addiction
Pain, memory problems and nicotine addiction are formidable problems that have quite different consequences. But in terms of what’s happening in the brain that causes people to suffer from each, they share a close connection. And now scientists say one drug might be able to help people with all three of these problems.
Estimates suggest 2 million people in the U.S. suffered from an opioid abuse disorder in 2015 (the most recent year with data available), about 5 million Americans are currently living with Alzheimer’s disease and more than 36 million Americans are currently cigarette smokers (more than half of w...
Source: Science - The Huffington Post - May 31, 2017 Category: Science Source Type: news
World No Tobacco Day
31 May isWorld No Tobacco Day. It is organized by the World Health Organization to highlight the health and other risks associated with tobacco use, and advocate for effective policies to reduce tobacco consumption. This year, the theme is on ' Tobacco and heart disease. 'In support of World No Tobacco Day, the Cochrane Library presents aSpecial Collection which highlights a selection of new or recently updated clinically relevant Cochrane Reviews that address tobacco addiction in the general population. There is free access to all reviews included.Evidently Cochrane blogs:Â What can nurses do to help people stop smoking?Â...
Source: Cochrane News and Events - May 31, 2017 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Researchers warn of hazards of smoking and need for wider use of varenicline to quit
More than 35 million Americans are trying to quit smoking. Researchers reassure clinicians and their patients that varenicline, whose brand name is Chantix, is a safe and effective way to achieve smoking cessation and that failure to use this drug has caused preventable heart attacks and deaths from cardiovascular disease. Just a few months ago, the FDA removed the black box warning from varenicline. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news
Researchers warn of hazards of smoking and need for wider use of varenicline to quit
(Florida Atlantic University) More than 35 million Americans are trying to quit smoking. Researchers reassure clinicians and their patients that varenicline, whose brand name is Chantix, is a safe and effective way to achieve smoking cessation and that failure to use this drug has caused preventable heart attacks and deaths from cardiovascular disease. Just a few months ago, the FDA removed the black box warning from varenicline. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 27, 2017 Category: Global & Universal Source Type: news
Smoking Cessation Drug May Boost Cognition in Schizophrenia Smoking Cessation Drug May Boost Cognition in Schizophrenia
The smoking cessation drug varenicline may help treat cognitive deficits in schizophrenia patients who smoke and allay worsening cognition when they try to quit.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 16, 2017 Category: Psychiatry Tags: Psychiatry News Source Type: news
Smoking-Cessation Meds, Counseling Work in Patients With CVD Smoking-Cessation Meds, Counseling Work in Patients With CVD
In contrast with some earlier research, a meta-analysis found that varenicline and bupropion along with counseling by phone or in person all seem effective in patients with cardiovascular disease.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
A combination of naltrexone + varenicline retards the expression of a genetic predisposition toward high alcohol drinking - Froehlich JC, Fischer SM, Nicholson ER, Dilley JE, Filosa NJ, Smith TN, Rademacher LC.
This study examined whether naltrexone (NTX) or varenicline (VAR), alone or in combination, can retard the phenotypic expression of a genetic predisposition toward high alcohol drinking in rats selectively bred for high alcohol intake when drug... (Source: SafetyLit)
Source: SafetyLit - January 14, 2017 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
La FDA revisa la descripci ó n de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropi ó n) para reflejar las conclusiones de estudio cl à nico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2017 Category: Drugs & Pharmacology Source Type: news
La FDA revisa la descripci ón de los efectos secundarios para la salud mental de los medicamentos para dejar de fumar Chantix (vareniclina) y Zyban (bupropión) para reflejar las conclusiones de estudio clÃnico
FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 5, 2017 Category: Drugs & Pharmacology Source Type: news
FDA Smokes Black Box Warning on Chantix FDA Smokes Black Box Warning on Chantix
Siding with an advisory committee, the FDA approved dropping the black box warning regarding possible serious neuropsychiatric side effects with Pfizer ' s smoking cessation drug varenicline.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - December 19, 2016 Category: Psychiatry Tags: Psychiatry News Source Type: news
Black Box Warnings Removed From Chantix, Zyban
(Source: WebMD Health)
Source: WebMD Health - December 19, 2016 Category: Consumer Health News Source Type: news
Health Highlights: Dec. 19, 2016
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Black Box Warnings Removed From Chantix and Zyban
The anti-smoking drug Chantix no longer has to carry a bold-letter warning about possible... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 19, 2016 Category: Journals (General) Source Type: news
FDA Removes Black Box Warning from Varenicline's Label (FREE)
By Kristin J. Kelley
Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH
The FDA has agreed to remove the black box warning from the label of the smoking-cessation drug, varenicline (Chantix). The warning alerted patients about the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 18, 2016 Category: Primary Care Source Type: news
